Sysojev, Anton Öberg
Frisell, Thomas
Delcoigne, Bénédicte
Saevarsdottir, Saedis
Askling, Johan
Westerlind, Helga
Funding for this research was provided by:
Vetenskapsrådet (2016-01355, 2018-02803)
NordForsk
VINNOVA
Region Stockholm/Karolinska Institutet Funds
Hjärt-Lungfonden
Stiftelsen Anna och Emil Olssons fond, Reumatikerförbundet (R-940868)
Stiftelsen Professor Nanna Svartz Fond (2020-00334)
Kung Gustav V:s 80 year foundation (FAI-2020-0666)
Karolinska Institutet foundations (2020-02508)
Karolinska Institute
Article History
Received: 12 January 2022
Accepted: 18 July 2022
First Online: 6 August 2022
Declarations
:
: This study was approved by the Stockholm ethical review board (2015/1844-31).
: Not applicable.
: Karolinska Institutet has entered into agreements with the following companies, with JA as PI: Abbvie, BMS, Eli Lilly, Janssen, Pfizer, Roche, Samsung Bioepis, and Sanofi. SS is a part-time employee as a researcher at deCODE genetics Inc.